|
1
|
Niu J, Wang Y, Yan S, Zhang Y, Ma X, Zhang Q, Zhang W. One-pot Ugi-azide and Heck reactions for the synthesis of heterocyclic systems containing tetrazole and 1,2,3,4-tetrahydroisoquinoline. Beilstein J Org Chem 2024; 20:912-920. [PMID: 38711586 PMCID: PMC11070971 DOI: 10.3762/bjoc.20.81] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2024] [Accepted: 04/11/2024] [Indexed: 05/08/2024] Open
Abstract
A new method for the synthesis of heterocyclic systems containing tetrazole and tetrahydroisoquinoline is developed via the performance of one-pot Ugi-azide and Heck cyclization reactions. The integration of the multicomponent and post-condensation reactions in one-pot maximizes the pot-, atom-, and step-economy (PASE).
Collapse
Affiliation(s)
- Jiawei Niu
- School of Pharmacy, Changzhou University, 1 Gehu Road, Changzhou 213164, China
| | - Yuhui Wang
- School of Pharmacy, Changzhou University, 1 Gehu Road, Changzhou 213164, China
| | - Shenghu Yan
- School of Pharmacy, Changzhou University, 1 Gehu Road, Changzhou 213164, China
| | - Yue Zhang
- School of Pharmacy, Changzhou University, 1 Gehu Road, Changzhou 213164, China
| | - Xiaoming Ma
- School of Pharmacy, Changzhou University, 1 Gehu Road, Changzhou 213164, China
| | - Qiang Zhang
- School of Chemistry and Life Sciences, Suzhou University of Science and Technology, 99 Xuefu Road, Suzhou 215009, China
| | - Wei Zhang
- Department of Chemistry and Center for Green Chemistry, University of Massachusetts Boston, 100 Morrissey Blvd, Boston, MA 02125, USA
| |
Collapse
|
|
2
|
Lu J, Shi Y, Li X, Liang X, Wang Y, Yuan S, Wu T. Understanding and Controlling the Formation of an N-Alkyl Impurity in Olmesartan Medoxomil: A Derivative via Michael-Type Addition between Tetrazole and Mesityl Oxide In Situ Generated from Acetone. Org Process Res Dev 2021. [DOI: 10.1021/acs.oprd.0c00506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Jianwu Lu
- State Key Lab of New Drug & Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 285 Gebaini Road, Pudong, Shanghai 201203, China
| | - Yinfei Shi
- State Key Lab of New Drug & Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 285 Gebaini Road, Pudong, Shanghai 201203, China
| | - Xiao Li
- State Key Lab of New Drug & Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 285 Gebaini Road, Pudong, Shanghai 201203, China
| | - Xiaomin Liang
- State Key Lab of New Drug & Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 285 Gebaini Road, Pudong, Shanghai 201203, China
| | - Yinquan Wang
- State Key Lab of New Drug & Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 285 Gebaini Road, Pudong, Shanghai 201203, China
| | - Shun Yuan
- State Key Lab of New Drug & Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 285 Gebaini Road, Pudong, Shanghai 201203, China
| | - Taizhi Wu
- State Key Lab of New Drug & Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, 285 Gebaini Road, Pudong, Shanghai 201203, China
| |
Collapse
|